Daniel Nebdal

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Xavier Tekpli, Tonje G. Lien, Andreas Hagen Røssevold et al. · Nature Communications · 2019 · 209 citations · Full text

Medicine, Immunology, Oncology +17

DNA methylation at enhancers identifies distinct breast cancer lineages

Thomas Fleischer, Xavier Tekpli, Anthony Mathelier et al. · Nature Communications · 2017 · 160 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

Jo Anders Rønneberg, Thomas Fleischer, Hiroko Kato Solvang et al. · Molecular Oncology · 2010 · 124 citations · Full text

Medicine, Genetics, Oncology +17

Intratumor heterogeneity defines treatment‐resistant <scp>HER</scp> 2+ breast tumors

Inga Hansine Rye, Anne Trinh, Anna Barbro Sætersdal et al. · Molecular Oncology · 2018 · 102 citations · Full text

Medicine, Cancer Biology, Oncology +17

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery

Åsa Kristina Öjlert, Ann Rita Halvorsen, Daniel Nebdal et al. · Molecular Oncology · 2019 · 94 citations · Full text

Medicine, Immunology, Oncology +17